Indirubin CAS: 479-41-4

CAS NO: 479-41-4
Indirubin
Chemical Name: Indirubin
Molecular Formula: C16H10N2O2
Formula Weight: 262.26
CAS No.: 479-41-4
Description Review
Description

Indirubin is a natural active ingredient that has been used in traditional Chinese medicine for centuries. It is derived from the indigo plant, and it has been found to have potential health benefits. Indirubin is a potent inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase-3β (GSK-3β), making it an attractive target for drug development.

Chemical name:

The chemical name of indirubin is 1H-indole-3-carboxaldehyde, 2-(1H-indol-3-yl) ethylidene-hydrazinecarboxamide.

Molecular formula:

The molecular formula of indirubin is C16H10N2O2.

Formula weight:

The formula weight of indirubin is 262.26 g/mol.

CAS No:

The CAS number of indirubin is 479-41-4.

Top Ten Keywords from Google:

  1. Indirubin cancer
  2. Indirubin side effects
  3. Indirubin mechanism of action
  4. Indirubin inflammation
  5. Indirubin dosage
  6. Indirubin diabetes
  7. Indirubin Alzheimer's disease
  8. Indirubin liver disease
  9. Indirubin neuroprotection
  10. Indirubin pharmacology

Synonyms:

Indirubin is also known as Dindruff Blue, Indigo red, Indigo purple, and 1H-Indole-3-carbaldehyde.

Health Benefits of Indirubin:

Several studies have shown that indirubin has potential health benefits. These include:

  1. Anti-inflammatory properties: Indirubin has been found to have anti-inflammatory properties that can help reduce swelling and pain caused by inflammation.

  2. Neuroprotective effects: Indirubin has been shown to improve cognitive function and protect against neurodegenerative diseases such as Alzheimer's disease.

  3. Anti-cancer effects: Indirubin has been found to inhibit the growth of cancer cells and induce cell death in several types of cancer, including leukemia, breast cancer, and lung cancer.

  4. Anti-diabetic effects: Indirubin has been shown to lower blood glucose levels and improve insulin sensitivity in diabetic mice.

  5. Liver protection: Indirubin has been found to protect the liver from damage caused by toxins and alcohol.

Potential Effects of Indirubin:

Indirubin has several potential effects due to its ability to inhibit CDKs and GSK-3β. These include:

  1. Cell cycle arrest: Indirubin can induce cell cycle arrest, which can prevent the growth and proliferation of cancer cells.

  2. Apoptosis: Indirubin can induce apoptosis, a process in which damaged or abnormal cells are eliminated.

  3. Inhibition of angiogenesis: Indirubin can inhibit angiogenesis, the formation of new blood vessels that is critical for tumor growth.

  4. Inhibition of inflammation: Indirubin can inhibit the production of pro-inflammatory cytokines, which can reduce inflammation.

Product Mechanism:

Indirubin works by inhibiting CDKs and GSK-3β. CDKs are enzymes that regulate the cell cycle, and they are often overexpressed in cancer cells. GSK-3β is involved in several signaling pathways that regulate cell growth, differentiation, and survival. By inhibiting CDKs and GSK-3β, indirubin can prevent the growth and proliferation of cancer cells and induce apoptosis.

Safety:

Indirubin has been found to be safe when used at recommended doses. However, it may cause mild side effects such as nausea, vomiting, and diarrhea.

Side Effects:

Some people may experience side effects such as headaches, dizziness, and fatigue when taking indirubin supplements. In rare cases, indirubin may cause liver damage, so it is important to monitor liver function when taking indirubin supplements.

Dosing Information:

There is no established dosage for indirubin supplements. However, most supplements contain 100-200 mg of indirubin per capsule. It is recommended to start with a low dose and gradually increase the dose if needed.

Conclusion:

Indirubin is a natural active ingredient that has potential health benefits. It has been found to have anti-inflammatory, neuroprotective, anti-cancer, and liver-protective effects. Indirubin works by inhibiting CDKs and GSK-3β, which are involved in cell growth and proliferation. Indirubin supplements are generally safe when used at recommended doses, although they may cause mild side effects in some individuals. Further research is needed to determine the optimal dosages and potential side effects of indirubin supplements.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code